Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 May 2019 | Story Lacea Loader | Photo Robin Thuynsma
Mr Nikile Ntsababa
Mr Nikile Ntsababa.

Mr Nikile Ntsababa took up the position of Registrar at the University of the Free State (UFS) on 1 May 2019. His appointment was approved by the UFS Council during its quarterly meeting on 15 March 2019.
 
“Mr Ntsababa is an experienced and knowledgeable university registrar with 10 years of senior management experience in institutional compliance, regulatory compliance, academic administration, and university records management. His history of senior roles in the higher-education sector has the advantage of a very good understanding regarding the dynamics, context, and challenges that the position of registrar brings,” says Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.
 
He holds a Postgraduate Diploma in Records and Archives Management from the University of Fort Hare, a Master of Public Administration from Nelson Mandela University, and a Bachelor of Arts in Communication from the University of Fort Hare. Some of the further certification and short courses he has completed includes a Certificate in International Higher Education Management from Vanderbilt University, Tennessee State in the USA, and a Compliance Management Certificate from the University of Cape Town. He is a Certified Ethics Officer.
 
Mr Ntsababa was Registrar at the Cape Peninsula University of Technology (CPUT) from April 2012 to April 2019; before that he was Deputy Registrar at CPUT from April 2009 to March 2012. He also served as Director of Governance at the University of Fort Hare from September 2007 to March 2009, and as Faculty Manager: Management and Commerce at the University of Fort Hare from January 2004 to August 2007.   
 
“I look forward to working at the UFS and to share my knowledge and experience of higher-education legislation and the associated regulatory processes, requirements, and trends in the higher-education sector,” says Mr Ntsababa.

Released by:

Lacea Loader (Director: Communication and Marketing)

Telephone: +27 51 401 2584 | +27 83 645 2454

Email: news@ufs.ac.za | loaderl@ufs.ac.za

Fax: +27 51 444 6393



News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept